Intrinsic Edge Capital Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,300,000
Closed -$1.94M 124
2024
Q3
$1.94M Hold
1,300,000
0.23% 86
2024
Q2
$1.63M Hold
1,300,000
0.15% 129
2024
Q1
$1.56M Sell
1,300,000
-500,000
-28% -$500K 0.12% 124
2023
Q4
$2.72M Buy
1,800,000
+1,500,000
+500% +$2.17M 0.27% 76
2023
Q3
$480K Buy
+300,000
New +$546K 0.05% 116
2022
Q1
Sell
-700,000
Closed -$3.37M 220
2021
Q4
$3.37M Buy
700,000
+200,000
+40% +$809K 0.21% 145
2021
Q3
$1.82M Hold
500,000
0.13% 180
2021
Q2
$2.02M Hold
500,000
0.12% 197
2021
Q1
$2.15M Hold
500,000
0.15% 192
2020
Q4
$1.98M Buy
+500,000
New +$2.09M 0.15% 177
2020
Q3
Sell
-176,600
Closed -$602K 276
2020
Q2
$602K Hold
176,600
0.06% 195
2020
Q1
$237K Sell
176,600
-500,000
-74% -$783K 0.03% 153
2019
Q4
$995K Buy
676,600
+176,600
+35% +$296K 0.13% 129
2019
Q3
$1.04M Hold
500,000
0.12% 135
2019
Q2
$1.22M Buy
+500,000
New +$1.09M 0.15% 105

Other funds holding OPK

Intrinsic Edge Capital Management's OPK Position: Q1 2025 in Review

Intrinsic Edge Capital Management sold out of Opko Health (OPK) in Q1 2025, closing a stake of 1,100,000 shares — an estimated $1.62M sold.

Intrinsic Edge Capital Management first reported a position in OPK in Q4 2016 and held it in 20 quarters. The position peaked at $3.71M in Q2 2020. 255 funds tracked by Wall St. Rank hold OPK as of Q1 2025.

  • Intrinsic Edge Capital Management reported no remaining Opko Health position as of Q1 2025 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 1,100,000 Opko Health shares in Q1 2025, an estimated $1.62M.
  • Intrinsic Edge Capital Management first reported a position in Opko Health in Q4 2016 and held it in 20 quarters.
  • Intrinsic Edge Capital Management's Opko Health position peaked at $3.71M in Q2 2020.
  • 255 funds tracked by Wall St. Rank held Opko Health as of Q1 2025.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2025, filed 12 May 2025.